title: Dolutegravir: successful experience in a challenging patient.
authors.affiliation: Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples 'Federico II', Naples, Italy.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Bonadies
authors.forename: Alberto Enrico
authors.initials: AE
authors.lastname: Maraolo
authors.forename: Orsola
authors.initials: O
authors.lastname: Tambaro
authors.forename: Giulia
authors.initials: G
authors.lastname: Palmiero
authors.forename: Giovanni
authors.initials: G
authors.lastname: Di Filippo
authors.forename: Raffaele
authors.initials: R
authors.lastname: Orlando
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D024882:Drug Resistance, Viral; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D019427:HIV Integrase / Q000235:genetics; D016333:HIV Protease / Q000235:genetics; D054303:HIV Reverse Transcriptase / Q000235:genetics; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics* / Q000302:isolation & purification; D006575:Heterocyclic Compounds, 3-Ring / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D020125:Mutation, Missense; D010078:Oxazines; D010879:Piperazines; D011728:Pyridones; D016896:Treatment Outcome; D019562:Viral Load; D000099226:Dolutegravir
chemical_list: D019380:Anti-HIV Agents; D019427:HIV Integrase; D016333:HIV Protease; D054303:HIV Reverse Transcriptase; D006575:Heterocyclic Compounds, 3-Ring; D010078:Oxazines; D010879:Piperazines; D011728:Pyridones; D000099226:Dolutegravir; C514824:reverse transcriptase, Human immunodeficiency virus 1; C514803:p16 protease, Human immunodeficiency virus 1; C514801:p31 integrase protein, Human immunodeficiency virus 1